Drreddys Laboratories | RDY - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
ANI Pharmaceuticals USD 82.79M 6.13M 2025-12
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Bayer EUR 4.05B 647M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Drreddys Laboratories INR 26.92B 3.74B 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Hikma Pharmaceutical USD 288M 149M 2025-12
Novartis USD 3.44B 128M 2025-12
Pacira USD 91.87M 70K 2025-12
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 29.67M 1.64M 2025-12
Richter Gedeon HUF 52.3B 6.68B 2025-09
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12